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In the present study, the hepatoprotective activity of ethanolic extracts of Cassia sophera Linn. leaves was evaluated against
carbon-tetrachloride- (CCl4-) induced hepatic damage in rats. The extracts at doses of 200 and 400mg/kg were administered
orally once daily. The hepatoprotection was assessed in terms of reduction in histological damage, changes in serum enzymes,
serum glutamate oxaloacetate transaminase (AST), serum glutamate pyruvate transaminase (ALT), serum alkaline phosphatase
(ALP), total bilirubin, and total protein levels. The substantially elevated serum enzymatic levels of AST, ALT, ALP, and total
bilirubin were restored towards the normalization signiﬁcantly by the extracts. The decreased serum total protein level was
signiﬁcantly normalized. Silymarin was used as standard reference and exhibited signiﬁcant hepatoprotective activity against
carbon tetrachloride-induced hepatotoxicity in rats. The biochemical observations were supplemented with histopathological
examination of rat liver sections. The results of this study strongly indicate that Cassia sophera leaves have potent hepatoprotective
action against carbon tetrachloride-induced hepatic damage in rats. This study suggests that possible activity may be due to the
presence of ﬂavonoids in the extracts.
1.Introduction
Cassia sophera Linn (Family Caesalpiniaceae), popularly
known as kasundi, is a shrubby herb found throughout
India and in most tropical countries. In the ethnobotanical
claims, the leaves are considered to be used for their anti-
inﬂammatory, antirheumatic, and purgative property, as
an expectorant for cough, cold, bronchitis, and asthma,
and in the treatment of liver disorders. Previous studies
have investigated on its pharmacological activities of the
seeds of C. sophera including analgesic and anticonvulsant
[1], antidiabetic [2], inhibition of lipid peroxidation [3],
herbicidal [4], and fungicidal [5]e ﬀects.
The chemical constituents of C. sophera include the
ﬂavonoids [6, 7] and anthraquinone [8, 9]. To the best of our
knowledge, there is no scientiﬁc report of hepatoprotective
eﬀectofC.sophera.Thus,thepresentstudywastoinvestigate
the hepatoprotective activity of ethanol extract of leaves of C.
sophera against CCl4-induced hepatic damage in rats.
2.MaterialsandMethods
2.1. Plant Material. The fresh leaves of Cassia sophera Linn
was collected from Tiruvannamalai district of Tamilnadu,
India, in October and November. The plant was identiﬁed by
B. Velmurugan, Taxonomist, Sri Ramana Maharishi Natural
Society, Tiruvannamalai, India. A voucher specimen (Reg.
no. GPT/8/2003) was deposited in our laboratory for future
references.Theleavesoftheplantweredriedundertheshade
and then milled into coarse powder, stored in an air tight
closed container.
2.2. Extraction and Isolation. The dried coarse powdered
Cassia sophera leaves (1.5kg) were ﬁrst defatted with
petroleum ether (60–80◦C) and then extracted with 5L
of ethanol (90%) in a soxhlet apparatus. The solvent was
then removed under reduced pressure, to obtain petroleum
ether (PECS, yield 8.5%) and ethanol extract (EECS, yield
22.5%), respectively. The ethanol extract was partitioned2 Evidence-Based Complementary and Alternative Medicine
successively between chloroform and ethyl acetate (3 ×
1L). The respective solvents were removed similarly under
reduced pressure, which produced ethyl acetate fraction
(EAF) (150g) and chloroform fraction (CF) (50g). Both
fractions were evaluated for hepatoprotective activity against
CCl4-induced hepatic damage in rats. EAF was found to
be more potent than CF. Hence, EAF was further exploited
for isolation, which led to the isolation of rhamnetin, O-
methylated ﬂavonol. The isolated bioactive metabolite was
characterized as rhamnetin based on melting point and
spectroscopic (IR, 1H NMR and MS) data [10, 11].
7g of the ethyl acetate fraction was adsorbed on silica gel
(silica gel 60G, Merck, 600g) and applied to a column of
silica gel. A gradient of chloroform:ethyl acetate:methanol
was used to elute the column, collecting 100 fractions of
50mL each. Fractions, 35–42, were combined and, on TLC,
it shows a single spot having an Rf value of 0.58. These
combined fractions are evaporated to dryness and were
further rechromatographed on a silica gel column using a
gradient elution with chloroform:ethyl acetate (8:2) to give
one compound, which was recrystallized with methanol to
give pure rhamnetin.
2.3. Animals. Adult male Wistar albino rats weighing 150–
180g were used for the present investigation. All animal
experiments were duly approved by Institutional Ethical
Committee (CPCSEA/ORG/CH/2006/Reg. no.95), Jadavpur
University, Kolkata, India.
2.4. Chemicals and Drugs. Silymarin was purchased from
Microlabs (Hosur, Tamilnadu, India), carbon tetrachloride
purchased from SICCO Research Laboratory, Mumbai,
India. All other chemicals and solvent were of analytical
grade and commercially available.
2.5. Acute Toxicity Test. The animals were divided into ﬁve
groups (n = 6). The EECS suspension was administrated
orally in increasing dose up to 2000mg/kg, b.w [12]. The
rats were observed continuously for 2h for behavioural,
neurological, and autonomic proﬁles and after 24 and 72h
for any lethality [13].
2.6. Experimental Design. The animals were divided into ﬁve
groups (n = 6 ) .G r o u pIs e r v e da sav e h i c l ec o n t r o l ,w h i c h
received liquid paraﬃn, intraperitoneally. Groups II–V were
treated with CCl4 in liquid paraﬃn (1:2) at the dose of
1mL/kg body weight (b.w) intraperitoneally once in every
72h for 16 days [14]. Aqueous suspension of EECS at the
doses of 200mg/kg and 400mg/kg, b.w, were administered
orally to the animals in groups III to IV in alternate days for
16 days. Group V received silymarin as a standard drug at the
dose of 25mg/kg, b.w., p.o. in alternate days for 16 days. At
the17thday,alltheratsweresacriﬁcedbycervicaldislocation
after collecting the blood from retroorbital plexus under
ether anesthesia for biochemical estimations. The blood
samples were allowed to clot and the serum was separated by
centrifugation at 5000rpm for 5min and used for the assay
of biochemical marker enzymes.
2.7. Biochemical Estimations. Diﬀerent biochemical parame-
ters like aspartate transaminase (AST), alanine transaminase
(ALT), alkaline phosphatase (ALP), total bilirubin and total
proteinweredeterminedbyusingcommerciallyavailablekits
(Span Diagnostic Limited, Surat, India).
2.8. Histological Observation. The washed liver tissues were
ﬁxed by using ﬁxative (picric acid, formaldehyde, and
40% glacial acetic acid) for 24h and dehydrated with
alcohol. Liver tissues were cleaned and embedded in paraﬃn
(melting point 58–60◦C), cut in 3–5μm sections, stained
with the haematoxylin-eosin dye and ﬁnally, observed under
a photomicroscope and morphological changes such as
cell necrosis, ballooning degeneration, fatty changes or
inﬂammation of lymphocytes were observed [15].
2.9. Statistical Analysis. The results were analyzed from
statistical signiﬁcance by one-way analysis of variance
(ANOVA) followed by Dunnett’s post hoc test using Statis-
tical Package of the Social Science (SPSS) software. Results
are expressed as mean ± SD for six rats in each group.
Diﬀerences among groups were considered signiﬁcant at P<
0.05 level.
3. Results
3.1. Phytochemical Screening and Isolation of Rhamnetin.
Preliminary phytochemical screening of the ethanol extract
of C. sophera revealed the presence of steroids, alkaloids,
tannins, saponins, and ﬂavonoids. Diﬀerent compositions
of the mobile phase were tested and the desired resolution
of rhamnetin with symmetrical and reproducible peak was
achieved by using the mobile phase chloroform and ethyl
acetate. The structure of the compound was characterized
by UV, IR, MS, and 13C-NMR methods as rhamnetin
(Figure 1). Structures and the IR, 13C-NMR, and MS
data obtained independently in these studies are in close
conformity with reported literature [10, 16].
yellow colour crystals, TLC: (chloroform:methanol,
9:1v/v)Rf 0.59: UV λmax (C2H5OH): 360.1nm; m.p. 282–
285◦C. MS m/z 316 (calculated value C16H12O7, 316.26). 1H
NMR (CD3OD): δ 13.04 (s, 1H, OH-5), δ 12.96 (s, 2H, OH-
3 ,4  ), δ 7.32–7.41 (d, 1H, H-6 ), δ 6.88 (d, 1H, J = 1.2,
H-5 ), δ 6.50 (d, 1H, J = 2, H-8), δ 6.43 (d, 1H, J = 2, H-
6), δ 3.78 (s, 3H, OCH3). The proton signal at δ 3.78 (s, 3H,
OCH3) suggests the location of –OCH3 at C-7, IR (KBr) v
cm−1, 3388 (O–H), 1654 (>C=O), 1610 (C=O), 1029 (C–O–
C).
3.2.AcuteToxicityStudies. Acutetoxicitystudiesrevealedthe
nontoxic nature of the ethanol extracts of Cassia sophera.
There was no lethality or toxic reaction found at any doses
selected until the end of the study period.
3.3. Hepatoprotective Activity. Rats treated with CCl4 devel-
oped a signiﬁcant hepatic damage and oxidative stress. This
is evident to the signiﬁcant (P<0.05) increase in serum ALT,
AST, ALP, and bilirubin levels in CCl4-treated rats comparedEvidence-Based Complementary and Alternative Medicine 3
Table 1: Eﬀect of EECS and silymarin on serum biochemical parameters.
Biochemical
parameters Control CCl4 1mL/kg MECS (200mg/kg) + CCl4 MECS (400mg/kg) + CCl4 Silymarin (50mg/kg) + CCl4
ALT (IU/L) 84 ±5.4 178.3 ±10.1a 151.6 ±11.1
∗ 135.3 ±3.4
∗ 120.0 ±3.9
∗
AST (IU/L) 143.3 ±14.8 251.6 ±11.9a 220.0 ±11.5
∗ 180.8 ±13.1
∗ 158.3 ±10.6
∗
ALP (IU/L) 82.2 ±7.8 190.0 ±13.9a 173.3 ±13.1
∗ 130.5 ±9.5
∗ 108 ±5.2
∗
Total protein (mg/dL) 6.9 ±0.32 3.5 ±0.46a 4.6 ± 0.28 5.2 ±0.21
∗∗ 6.0 ±0.31
Total bilirubin
(mg/dL) 0.29 ±0.04 0.98 ±0.07a 0.79 ±0.07 0.63 ±0.05
∗∗ 0.48 ±0.07
∗
Values are mean ± SEM (n = 6). ∗P<0.01 (moderately signiﬁcant), ∗∗P<0.05 (signiﬁcant) as compared with CCl4, a: signiﬁcant as compared with control
(P<0.01).
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Figure 1: Structure of Rhamnetin.
to normal rats. However, the serum total protein level was
signiﬁcantly (P<0.05) decreased in CCl4-intoxicated rats.
The toxic eﬀects of CCl4 were controlled in the animals
treated with methanol extract of Cassia sophera at the doses
of 200 and 400mg/kg, p.o. signiﬁcantly (P<0.05) decreased
the elevated serum marker enzymes. Total bilirubin and total
proteins were found to be restored to almost normal level.
The eﬀects of EECS on serum ALT, AST, ALP, bilirubin and
total protein levels in CCl4 intoxicated rats are summarized
in Table 1.
Histological observations of the liver tissue of the normal
animals showed hepatic cells with well-preserved cytoplasm,
nucleus, nucleolus, and central vein (Figure 2(a); 10x).
Treatment with CCl4 caused fatty degeneration with severe
necrosis of the parenchyma cells in the central lobular
region of the liver. Furthermore, hepatocytic necrosis was
predominant surrounding the central vein, which formed a
streak-like appearance (Figure 2(b); 10x). Figures 2(c), 2(d)
and 2(e) (10x) show animals treated with EECS (200 and
400mg/kg, p.o.) and Silymarin (25mg/kg) and restored the
altered histopathological changes, respectively.
4. Discussion
Preventive action in liver damage induced by carbon tetra-
chloride has widely been used as an indicator of the liver
protective activity of drugs in general [17]. It was found
that chronic administration of CCl4 produces liver cirrhosis
in rats. It is well documented that carbon tetrachloride
is biotransformed under the action of cytochrome P-
450 system in the microsomal compartment of liver to
trichloromethyl or peroxytrichloromethyl free radical. These
free radicals bind covalently to the macromolecules and
induce peroxidative degradation of the membrane lipids of
endoplasmic reticulum rich in polyunsaturated fatty acids.
This leads to the formation of lipid peroxides followed by
pathological changes such as triacylglycerol accumulation,
polyribosomal disaggregation, depression of protein synthe-
sis, cell membrane breakdown, and even death [18, 19].
Estimating the activities of serum marker enzymes like
AST, ALT, ALP, and bilirubin can make assessment of liver
function. When liver cell plasma membrane is damaged,
a variety of enzymes normally located in the cytosol are
releasedintothebloodstream.Theirestimationintheserum
is a useful quantitative marker of the extent and type of
hepatocellular damage [20].
The increased level of AST, ALT, ALP, and bilirubin is
conventional indicator of the liver injury. In the present
study, it is observed that administration of CCl4 elevates
the levels of serum marker enzymes AST, ALT, ALP, and
bilirubin. Levels of total proteins are lowered. Ethanol
extracts of Cassia sophera and reference drug silymarin-
treated groups exhibited lower levels of AST, ALT, ALP, and
bilirubin as compared to CCl4 treated groups. The treatment
with MECS also signiﬁcantly elevated total protein levels.
The stabilization of serum AST, ALT, ALP and bilirubin
by EECS is clear indication of the improvement of the
functional status of the liver cells. The characteristic feature
of experimental hepatic damage observed is signiﬁcant
decrease in protein level. The rats in group IV, which receive
EECS, showed restoration of protein levels.
These ﬁndings can be further corroborated with his-
topathological studies. The histopathological examination
clearly reveals that the hepatic cells, central vein, and portail
triad are almost normal in EECS (400mg/kg. p.o.) group in
contrast to group IV, which receive CCl4 only. Thus EECS
c a nb ec o n s i d e r e dt ob ea ne ﬀective hepatoprotective as it
ameliorates almost to normalcy the damage caused by CCl4
to hepatic function.
As the ﬂavonoid compound isolated from Artemisia
scorparia[21]isreportedtopossesshepatoprotectiveactivity,4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Photomicroscopy of liver sections from CCl4-intoxicated rats (10x). Histological observations of the liver tissue of the normal
animals showed hepatic cells with well-preserved cytoplasm, nucleus, nucleolus, and central vein (a). Treatment with CCl4 caused fatty
degeneration with severe necrosis of the parenchyma cells in the central lobular region of the liver. Furthermore, hepatocytic necrosis was
predominant surrounding the central vein, which formed a streak-like appearance (b), (c), (d), and (e) showed animals treated with EECS
(200 and 400mg/kg, p.o.) and silymarin (25mg/kg) and restored the altered histopathological changes, respectively.
it is very likely that the ﬂavonoid glycoside in C. sophera [22]
may be responsible for hepatoprotective activity, but further
exploration is needed.
5. Conclusion
The ethanolic extract of Cassia sophera could eﬀectively
control the AST, ALT, ALP, and total bilirubin levels and
increase the protein levels in the protective studies. The
histopathological studies also substantiate the activity of the
drug. Therefore, the study scientiﬁcally supports the usage
of this plant in traditional medicine for treatment of liver
disorders and as a tonic.
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